We describe various types of outliers seen in Affymetrix GeneChip data. We have been able to utilise the data in the Gene Expression Omnibus to screen GeneChips across a range of scales, from single probes, to spatially adjacent fractions of arrays, to whole arrays, to whole experiments. In this review we describe a number of causes for why some reported intensities might be misleading on GeneChips.

Download full-text PDF

Source
http://dx.doi.org/10.1093/bfgp/elp027DOI Listing

Publication Analysis

Top Keywords

outliers affymetrix
8
affymetrix genechip
8
genechip data
8
data describe
4
describe types
4
types outliers
4
data utilise
4
utilise data
4
data gene
4
gene expression
4

Similar Publications

We detail the development of the ancestry informative single nucleotide polymorphisms (SNPs) panel forming part of the VISAGE Basic Tool (BT), which combines 41 appearance predictive SNPs and 112 ancestry predictive SNPs (three SNPs shared between sets) in one massively parallel sequencing (MPS) multiplex, whereas blood-based age analysis using methylation markers is run in a parallel MPS analysis pipeline. The selection of SNPs for the BT ancestry panel focused on established forensic markers that already have a proven track record of good sequencing performance in MPS, and the overall SNP multiplex scale closely matched that of existing forensic MPS assays. SNPs were chosen to differentiate individuals from the five main continental population groups of Africa, Europe, East Asia, America, and Oceania, extended to include differentiation of individuals from South Asia.

View Article and Find Full Text PDF

Breast cancer is one of the most common cancers among women, and susceptibility is explained by genetic, lifestyle and environmental components. Copy Number Variants (CNVs) are structural DNA variations that contribute to diverse phenotypes via gene-dosage effects or cis-regulation. In this study, we aimed to identify germline CNVs associated with breast cancer susceptibility and their relevance to prognosis.

View Article and Find Full Text PDF

Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of Head and Neck Cancer.

PLoS One

July 2016

Integrated Head and Neck Oncology Program, Mazumdar Shaw Centre for Translational Research, Mazumdar Shaw Medical Centre, Narayana Health, Bangalore, Karnataka, India.

Article Synopsis
  • This study aimed to identify clinically relevant biomarkers for head and neck squamous cell carcinoma (HNSCC) by analyzing data from 20 public microarray series, focusing on gene expression differences between normal and tumor samples.
  • A total of 181 differentially expressed genes were identified, with significant interactions among many of them, and a gene panel (ECT2, ANO1, TP63, FADD, EXT1, NCBP2) was linked to alterations in about 30% of the tested tumor samples.
  • Validation in patient groups showed specific genes like ANO1 and FADD could predict recurrence and treatment response, indicating their potential as biomarkers for monitoring disease outcomes in HNSCC patients.
View Article and Find Full Text PDF

Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.

Eur Urol

October 2015

Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address:

Background: Prostate cancer (PCa) molecular subtypes have been defined by essentially mutually exclusive events, including ETS gene fusions (most commonly involving ERG) and SPINK1 overexpression. Clinical assessment may aid in disease stratification, complementing available prognostic tests.

Objective: To determine the analytical validity and clinicopatholgic associations of microarray-based molecular subtyping.

View Article and Find Full Text PDF

Motivation: Microarray results accumulated in public repositories are widely reused in meta-analytical studies and secondary databases. The quality of the data obtained with this technology varies from experiment to experiment, and an efficient method for quality assessment is necessary to ensure their reliability.

Results: The lack of a good benchmark has hampered evaluation of existing methods for quality control.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!